Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| T32DK007074 | Digestive Health and Diseases (DHD) Training Grant | 1 | 2024 |
| U01AG068057 | Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease Biobanks | 1 | 2024 |
| U01NS117209 | Novel pediatric anticonvulsants for nerve agents | 1 | 2024 |
| UL1TR001427 | Together: Transforming and Translating Discovery to Improve Health | 1 | 2024 |
| R01AG017917 | Epidemiologic Study of Neural Reserve and Neurobiology of Aging | 8 | 2023 |
| P20GM103641 | Dietary Supplements and Inflammation Phase-2: Isoxanthohumol as a treatment for estrogen-deficient-induced visceral hyperalgesia. | 4 | 2023 |
| R01AA020744 | MicroRNAs in Alcoholic Liver Disease | 3 | 2023 |
| R01MH106056 | Higher Order Chromatin and Genetic Risk for Schizophrenia | 3 | 2023 |
| R01NS051630 | Molecular Basis of rCGG-Mediated Neurodegeneration | 3 | 2023 |
| P01AG017242 | DNA Repair, Mutations and Cellular Aging | 2 | 2023 |
| R00ES029537 | PCB induced neurogenic inflammation mediates bladder dysfunction | 2 | 2023 |
| R01AG069333 | Mitochondrial Molecules as Therapeutic Drugs for Alzheimer's Disease | 2 | 2023 |
| R01CA222490 | Liver Cancer Therapy by MiR-22 and Its Inducers | 2 | 2023 |
| R01HL143892 | Restoration of myocardial reparative function of diabetic progenitor cells by epigenetic modulation | 2 | 2023 |
| R01HL146691 | Functional role of IP3 receptors in the regulation of cardiac myofibroblasts | 2 | 2023 |
| R01MH117122 | Epigenetic roles of DNA adenine methylation in stress response | 2 | 2023 |
| U54NS065705 | Brain Vascular Malformation Consortium: Predictor's of Clinical Course | 2 | 2023 |
| F31CA261096 | Melanoma NAMPT mediates resistance to the anti-proliferative effects of Interferons (IFNs) and IFN based immunotherapies such as STING Agonists | 1 | 2023 |
| F31MH124282 | Using microRNA-target chimeras to study post-transcriptional gene regulation in the mammalian CNS | 1 | 2023 |
| K00CA234799 | Novel relationships of splicing factors in temozolomide-resistant glioblastoma | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=16